NCT07193719

Brief Summary

The goal of this randomized interventional clinical trial is to learn if a standardized lung volume optimization maneuver (LVOM) is beneficial in

  • cardiac performance
  • lung function Does it make a difference in:
  • length of ventilation
  • ventilation/perfusion mismatch of the lung
  • need for vasopressor support? Main hypotheses of ECMO study: Does a LVOM in children/infants with severe respiratory failure /ARDS
  • improve lung compliance and gas exchange
  • facilitate lung protective ventilation according to PALICC-2 guidelines
  • improve lung aeration and V/Q-matching assessed with EIT Does it make a difference in
  • need for ECMO
  • duration of ECMO runs
  • hemodynamics stability

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P75+ for phase_1

Timeline
19mo left

Started Dec 2025

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Dec 2025Dec 2027

First Submitted

Initial submission to the registry

September 11, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 26, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

December 5, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2027

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

1.5 years

First QC Date

September 11, 2025

Last Update Submit

April 5, 2026

Conditions

Keywords

cardiopulmonary interactionsend-expiratory lung volumePEEP titrationARDSECMOcardiopulmonary bypass

Outcome Measures

Primary Outcomes (1)

  • CHD study: Cardiac Index (L/min/BSA) 2. ECMO study: shortening of ECMO duration (Hours)

    CHD study: assessed by using POCUS ECMO study: time course (Hours)

    perioperatively/periprocedurally

Secondary Outcomes (6)

  • lung mechanics

    perioperatively/periprocedurally

  • right ventricular performance

    perioperatively/periprocedurally

  • Ventilation distribution

    perioperatively/periprocedurally

  • Lung perfusion

    perioperatively/periprocedurally

  • dead space

    perioperatively/periprocedurally

  • +1 more secondary outcomes

Study Arms (2)

control

ACTIVE COMPARATOR

CHD study: This group receives so called standard of care. This includes relatively low levels of PEEP (5cmH2O in case of planned surgery) and no standardized PEEP titration ECMO study: This group receives so called standard of care. This includes PEEP of 10cmH2O, peak inspiratory pressures of 20cmH2O and no standardized PEEP titration

Procedure: Standard Care (in control arm)

treatment

EXPERIMENTAL

CHD study: This group receives an individual lung volume optimization maneuver with PEEP titration. PEEP titration is performed while monitoring lung mechanics to optimize end-expiratory lung volume and find final "best PEEP". ECMO study: This group receives an individual lung volume optimization maneuver with PEEP titration during conventional or CDP titration with high frequency oscillatory ventilation. PEEP/CDP titration is performed while monitoring lung mechanics and EIT indices to optimize end-expiratory lung volume and find final "best PEEP/CDP".

Procedure: End-expiratory lung volume optimization maneuver with PEEP titration

Interventions

CHD study: PEEP titration (incremental/decremental) will be performed to optimize lung volume and find levels of PEEP corresponding to the best lung compliance at the end of surgery. Typically PEEP levels between 10-20cmH2O will be applied based on individual response of patients' lung mechanics. Tidal volume will be kept constant at 6ml/kg in cases and controls. Driving pressures will be limited to 15cmH2O. Balance of CO2 will be guaranteed by adjusting respiratory rate. ECMo study: PEEP/CDP titration (incremental/decremental) will be performed to optimize lung volume and find levels of PEEP/CDP corresponding to the best lung compliance, best match of overdistension and collapse and homogenization of tidal volume distribution (EIT) .

treatment

CHD study: Patients will receive pressure controlled ventilation with target tidal volume of 6ml/kg and PEEP of 5cmH2O. Driving pressures are limited to 15cmH2O. No LVOM will be applied. ECMO study: patients will receive standard ECMO ventilation (PEEP 10cmH2O and PiP 20cmH2O) without performing LVOM

control

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • congenital heart disease
  • surgery with cardiopulmonary bypass

You may not qualify if:

  • single ventricle physiology
  • ECMO/VAD
  • \<36weeks of gestational age
  • chronic lung disease
  • Endotracheal tube leak \> 15%
  • lack of informed consent from parents.
  • patients with respiratory failure on ECMO or at risk for ECMO
  • invasive ventilation
  • \- severe lung hypoplasia or interstitial lung disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

German Heart Center of the Charité

Berlin, 13353, Germany

RECRUITING

MeSH Terms

Conditions

Heart Defects, Congenital

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Jan C Clausen, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Statisticians
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The type of intervention is one of clinical management (ventilatory management) and does not include a specific drug or biological
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Cardiologist/Intensivist

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 26, 2025

Study Start

December 5, 2025

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

December 20, 2027

Last Updated

April 9, 2026

Record last verified: 2026-04

Locations